Trials / Sponsors / Åslaug Helland
Åslaug Helland
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Cancer, Cancer, Lung, Cancer of Lung | Phase 2 | 2020-05-04 |